The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Challenges and Opportunities in dermal/transdermal Delivery
Open accessAbstract
Transdermal drug delivery is an exciting and challenging area. There are numerous transdermal delivery systems currently available on the market. However, the transdermal market still remains limited to a narrow range of drugs. Further advances in transdermal delivery depend on the ability to overcome the challenges faced regarding the permeation and skin irritation of the drug molecules. Emergence of novel techniques for skin permeation enhancement and development of methods to lessen skin irritation would widen the transdermal market for hydrophilic compounds, macromolecules and conventional drugs for new therapeutic indications. As evident from the ongoing clinical trials of a wide variety of drugs for various clinical conditions, there is a great future for transdermal delivery of drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1992) · Applied Ergonomics · doi:10.1016/0003-6870(92)90318-p · Cited by 5,737
Prausnitz, M. R., & Langer, R. (2008) · Nature Biotechnology · doi:10.1038/nbt.1504 · Cited by 3,517
Microneedles for transdermal drug delivery
Prausnitz, M. R. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.023 · Cited by 1,521
The 500 Dalton rule for the skin penetration of chemical compounds and drugs
Bos, J. D., & Meinardi, M. M. H. M. (2000) · Experimental Dermatology · doi:10.1034/j.1600-0625.2000.009003165.x · Cited by 1,465
Current status and future potential of transdermal drug delivery
Prausnitz, M. R., Mitragotri, S., & Langer, R. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1304 · Cited by 1,462
Microfabricated Microneedles: A Novel Approach to Transdermal Drug Delivery
Henry, S., McAllister, D. V., Allen, M. G., & Prausnitz, M. R. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980042+ · Cited by 1,346
The pH of the Skin Surface and Its Impact on the Barrier Function
Schmid-Wendtner, M.-H., & Korting, H. C. (2006) · Skin Pharmacology and Physiology · doi:10.1159/000094670 · Cited by 860
Drug permeation through human skin: Theory and invitro experimental measurement
Michaels, A. S., Chandrasekaran, S. K., & Shaw, J. E. (1975) · AIChE Journal · doi:10.1002/aic.690210522 · Cited by 801
Ultrasound-Mediated Transdermal Protein Delivery
Mitragotri, S., Blankschtein, D., & Langer, R. (1995) · Science · doi:10.1126/science.7638603 · Cited by 791
Coated microneedles for transdermal delivery
Gill, H. S., & Prausnitz, M. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.017 · Cited by 765
Microemulsions as transdermal drug delivery vehicles
Kogan, A., & Garti, N. (2006) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2006.05.014 · Cited by 680
Nanotechnology and the transdermal routeA state of the art review and critical appraisal
Cevc, G., & Vierl, U. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.016 · Cited by 560
Terpenes and the Lipid–Protein–Partitioning Theory of Skin Penetration Enhancement
Williams, A. C., & Barry, B. W. (1991) · Pharmaceutical Research · doi:10.1023/a:1015813803205 · Cited by 550
Micro-scale devices for transdermal drug delivery
Arora, A., Prausnitz, M. R., & Mitragotri, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.032 · Cited by 464
Design principles of chemical penetration enhancers for transdermal drug delivery
Karande, P., Jain, A., Ergun, K., Kispersky, V., & Mitragotri, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501176102 · Cited by 399
Enhancement of transdermal drug delivery via synergistic action of chemicals
Karande, P., & Mitragotri, S. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.08.015 · Cited by 399
Minimally Invasive Protein Delivery with Rapidly Dissolving Polymer Microneedles
Sullivan, S. P., Murthy, N., & Prausnitz, M. R. (2008) · Advanced Materials · doi:10.1002/adma.200701205 · Cited by 391
(1995) · PubMed · Cited by 375
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
Wermeling, D. P., Banks, S. L., Hudson, D. A., Gill, H. S., Gupta, J., Prausnitz, M. R., & Stinchcomb, A. L. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710355105 · Cited by 311
Self-citationLipid-Protein-Partitioning theory of skin penetration enhancement
Barry, B. W. (1991) · Journal of Controlled Release · doi:10.1016/0168-3659(91)90115-t · Cited by 301
Discovery of transdermal penetration enhancers by high-throughput screening
Karande, P., Jain, A., & Mitragotri, S. (2004) · Nature Biotechnology · doi:10.1038/nbt928 · Cited by 280
A practical assessment of transdermal drug delivery by skin electroporation
Prausnitz, M. R. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00063-5 · Cited by 207
Chen, H., Zhu, H., Zheng, J., Mou, D., Wan, J., Zhang, J., Shi, T., Zhao, Y., Xu, H., & Yang, X. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.031 · Cited by 202
Pillai, O. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00094-4 · Cited by 172
Tang, H., Wang, C. C. J., Blankschtein, D., & Langer, R. (2002) · Pharmaceutical Research · doi:10.1023/a:1019898109793 · Cited by 170
How irritant is water? An overview
Tsai, T., & Maibach, H. I. (1999) · Contact Dermatitis · doi:10.1111/j.1600-0536.1999.tb06990.x · Cited by 167
Percutaneous Penetration Enhancers: An Overview
Thong, H.-Y., Zhai, H., & Maibach, H. I. (2007) · Skin Pharmacology and Physiology · doi:10.1159/000107575 · Cited by 167
Johnson, W. A. (2007) · International Journal of Toxicology · doi:10.1080/10915810601163939 · Cited by 166
Liposomes in dermatology today
De Leeuw, J., De Vijlder, H., Bjerring, P., & Neumann, H. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03100.x · Cited by 162
Determination of threshold energy dose for ultrasound-induced transdermal drug transport
Mitragotri, S., Farrell, J., Tang, H., Terahara, T., Kost, J., & Langer, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00178-9 · Cited by 160
Cross, S. E., & Roberts, M. S. (2004) · Current Drug Delivery · doi:10.2174/1567201043480045 · Cited by 152
Skin Irritation and Sensitization: Mechanisms and New Approaches for Risk Assessment
Fluhr, J. W., Darlenski, R., Angelova‐Fischer, I., Tsankov, N., & Basketter, D. (2008) · Skin Pharmacology and Physiology · doi:10.1159/000131077 · Cited by 150
Microporation applications for enhancing drug delivery
Banga, A. K. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902841935 · Cited by 149
Fang, J.-Y., Lee, W.-R., Shen, S.-Y., Fang, Y., & Hu, C.-H. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06051.x · Cited by 141
Electrically-Assisted Transdermal Drug Delivery
Riviere, J. E., & Heit, M. C. (1997) · Pharmaceutical Research · doi:10.1023/a:1012129801406 · Cited by 140
Transdermal Drug Delivery by Jet Injectors: Energetics of Jet Formation and Penetration
Schramm, J., & Mitragotri, S. (2002) · Pharmaceutical Research · doi:10.1023/a:1020753329492 · Cited by 139
The effect of heat on skin permeability
Park, J., Lee, J.-W., Kim, Y., & Prausnitz, M. R. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.03.032 · Cited by 139
Skin Irritation and Sensitization: Mechanisms and New Approaches for Risk Assessment
Basketter, D., Darlenski, R., & Fluhr, J. W. (2008) · Skin Pharmacology and Physiology · doi:10.1159/000135635 · Cited by 138
Remington's Practice of Pharmacy
(1956) · JAMA · doi:10.1001/jama.1956.02970010118047 · Cited by 107
Lee, W.-R., Shen, S., Lai, H.-H., Hu, C., & Fang, J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00391-1 · Cited by 107
Mid-Infrared Laser Ablation of Stratum Corneum Enhances In Vitro Percutaneous Transport of Drugs
Nelson, J. S., McCullough, J. L., Glenn, T. C., Wright, W. H., Liaw, L. L., & Jacques, S. L. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12491600 · Cited by 97
Skin irritation caused by transdermal drug delivery systems during long-term (5 days) application
HURKMANS, J. F. G. M., Boddé, H. E., van Driel, L. M. J., van Doorne, H., & Junginger, H. E. (1985) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1985.tb02321.x · Cited by 94
Johnson, W. A. (2007) · International Journal of Toxicology · Cited by 93
Wester, R. C., Patel, R., Nacht, S., Leyden, J., Melendres, J. L., & Maibach, H. I. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70109-f · Cited by 91
Galinkin, J. L., Rose, J. B., Harris, K. M., & Watcha, M. F. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200206000-00020 · Cited by 86
Karande, P., Jain, A., & Mitragotri, S. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.001 · Cited by 85
Selective removal of stratum corneum by microdermabrasion to increase skin permeability
Gill, H. S., Andrews, S. N., Sakthivel, S. K., Fedanov, A., Williams, I. R., Garber, D. A., Priddy, F. H., Yellin, S. A., Feinberg, M. B., Staprans, S. I., et al. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.06.004 · Cited by 84
Liposomal tretinoin for uncomplicated acne vulgaris
Sch�fer-Korting, M., Korting, H. C., & Ponce-P�schl, E. (1994) · The Clinical Investigator · doi:10.1007/bf00577761 · Cited by 81
Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation
Lanke, S. S. S., Kolli, C. S., Strom, J. G., & Banga, A. K. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.08.028 · Cited by 80
Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis
Dean, H. J., FULLER, D. H., & Osorio, J. E. (2003) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/s0147-9571(03)00021-3 · Cited by 68
Dystonia in the Woodhouse Sakati syndrome: A new family and literature review
Schneider, S. A., & Bhatia, K. P. (2008) · Movement Disorders · doi:10.1002/mds.21886 · Cited by 67
pH‐induced alterations in stratum corneum properties
Ananthapadmanabhan, K. P., Lips, A., Vincent, C. K., Meyer, F., Caso, S., Johnson, A. W., Subramanyan, K., Vethamuthu, M. S., Rattinger, G., & Moore, D. J. (2003) · International Journal of Cosmetic Science · doi:10.1046/j.1467-2494.2003.00176.x · Cited by 66
Long‐term repetitive sodium lauryl sulfate‐induced irritation of the skin: an in vivo study
Branco, N., Lee, I., Zhai, H., & Maïbach, H. I. (2005) · Contact Dermatitis · doi:10.1111/j.0105-1873.2005.00703.x · Cited by 63
Zewert, T. E., Pliquett, U. F., Rita Vanbever, A., Langer, R., & Weaver, J. C. (1999) · Bioelectrochemistry and Bioenergetics · doi:10.1016/s0302-4598(99)00056-2 · Cited by 62
Wilson, D. E., Kaidbey, K. H., Boike, S. C., & Jorkasky, D. K. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80093-3 · Cited by 59
Squire, S. J., Kirchhoff, K. T., & Hissong, K. (2000) · Journal of Pediatric Health Care · doi:10.1016/s0891-5245(00)79847-6 · Cited by 58
Gupta, S., Bernstein, K. J., Noorduin, H., Peer, A. V., Sathyan, G., & Haak, R. (1998) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1998.tb04392.x · Cited by 57
Banks, S. L., Reddy, P. R., Gill, H. S., Crooks, P. A., Prausnitz, M. R., & Stinchcomb, A. L. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9578-3 · Cited by 55
Self-citationWigger‐Alberti, W., Hinnen, U., & Elsner, P. U. (1997) · Contact Dermatitis · doi:10.1111/j.1600-0536.1997.tb00916.x · Cited by 52
Suzuki, Y., Nagase, Y., Iga, K., Kawase, M., Oka, M., Yanai, S., Matsumoto, Y., Nakagawa, S., Fukuda, T., Adachi, H., et al. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10019 · Cited by 51
Mangia, A., Andersen, P. H., Berner, B., & Maïbach, H. I. (1996) · Contact Dermatitis · doi:10.1111/j.1600-0536.1996.tb02192.x · Cited by 49
Ben‐Shabat, S., Baruch, N., & Sintov, A. C. (2007) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040701199258 · Cited by 44
Patel, S., Zhong, H., Sharma, A., et al. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.08.006 · Cited by 43
Homick, J. L., Kohl, R. L., Mf, R., Degioanni, J. J., & Cintrón, N. M. (1983) · PubMed · Cited by 42
Microneedles and transdermal drug delivery
Kalluri, H., & Banga, A. K. (2009) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(09)50065-2 · Cited by 41
Penetration Enhancers Assessed by Corneoxenometry
Goffin, V., Henry, F., Piérard-Franchimont, C., et al. (2000) · Skin Pharmacology and Physiology · doi:10.1159/000029934 · Cited by 39
Warwick, W. J., Huang, N. Ν., Waring, W. W., Cherian, A., Brown, I. K., Stejskal-Lorenz, E., Yeung, W. H., Duhon, G., Hill, J., & Strominger, D. B. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.5.850 · Cited by 35
Anti‐irritants I: dose–response in acute irritation
Andersen, F., Hedegaard, K. L., Petersen, T. K., Bindslev‐Jensen, C., Fullerton, A., & Andersen, K. E. (2006) · Contact Dermatitis · doi:10.1111/j.1600-0536.2006.00752.x · Cited by 31
Kiptoo, P. K., Paudel, K. S., Hammell, D. C., Reddy, P. R., Chen, J., Crooks, P. A., & Stinchcomb, A. L. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21463 · Cited by 31
Self-citationSingh, J., Gross, M., Sage, B. H., Davis, H. T., & Maïbach, H. I. (2001) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(01)00057-6 · Cited by 27
Transdermal Drug Delivery System: Patent Reviews
Samad, A., Ullah, Z., Alam, M. I., Wais, M., & Shams, M. (2009) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221109788452294 · Cited by 25
Fang, J., Tsai, M., Huang, Y., Wu, P., & Tsai, Y. (1997) · Drug Development Research · Cited by 23
Human Skin Sermeation of 3-O-Alkyl Carbamate Prodrugs of Naltrexone
Vaddi, H. K., Banks, S. L., Chen, J., Hammell, D. C., Crooks, P. A., & Stinchcomb, A. L. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21594 · Cited by 19
Self-citationAndersen, F., Hedegaard, K. L., Petersen, T. K., Bindslev‐Jensen, C., Fullerton, A., & Andersen, K. E. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.08.063 · Cited by 18
Cited by
Alkilani, A., McCrudden, M. T., & Donnelly, R. (2015) · Pharmaceutics · doi:10.3390/pharmaceutics7040438 · Cited by 1,147
Larrañeta, E., Lutton, R. E. M., Woolfson, A. D., & Donnelly, R. F. (2016) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2016.03.001 · Cited by 964
Ahmed, T., & Aljaeid, B. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s99651 · Cited by 705
Enhancement strategies for transdermal drug delivery systems: current trends and applications
Ramadon, D., McCrudden, M. T. C., Courtenay, A. J., & Donnelly, R. F. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-00909-6 · Cited by 649
Rai, V. K., Mishra, N., Yadav, K. S., & Yadav, N. P. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.049 · Cited by 619
Metadata
- Authors
- Paudel, K. S., Milewski, M., Swadley, C. L., Brogden, N. K., Ghosh, P., & Stinchcomb, A. L.
- Venue
- Therapeutic Delivery
- Publisher
- Informa UK Limited
- Published
- 2010-06-25
- Volume
- 1
- Issue
- 1
- Pages
- 109-131
- ISSN
- 2041-5990 (ISSN-L)
- 2041-6008
- OpenAlex
- W2016181184
- Cited by
- 616
- References
- 74
- FWCI
- 5.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.